Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Helex Secures $3.5M Seed Round Led by Pi Ventures
SeedVenture Capital

Helex Secures $3.5M Seed Round Led by Pi Ventures

•October 30, 2025
•Oct 30, 2025
0

Participants

Helex

Helex

company

pi Ventures

pi Ventures

investor

Bluehill

Bluehill

investor

SOSV

SOSV

investor

Why It Matters

The infusion of capital accelerates Helex’s path to market for a high‑unmet‑need disease area, positioning the firm to capture value as the first mover in genetically‑targeted kidney treatments.

Deal Summary

NYC‑based therapeutics firm Helex announced a $3.5 million seed financing to advance its targeted medicines for genetic kidney diseases. The round was led by pi Ventures with participation from Bluehill Capital, SOSV and a broader syndicate of investors.

0

Comments

Want to join the conversation?

Loading comments...